United States
You have no items in your shopping cart.
c-Ret
5 Item(s)
per page
| Catalog No. | Product Name | Application | Product Information |
|---|---|---|---|
A10715 SALE |
Danusertib (PHA-739358) |
Aurora inhibitor |
Danusertib (PHA-739358) is a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor
|
A10250 SALE |
Regorafenib (BAY 73-4506) |
VEGFR inhibitor |
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature.
|
A15218 |
Regorafenib monohydrate |
Tyrosine kinase inhibitor |
Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR??, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively.
|
A13832 SALE |
RPI-1 |
Ret kinase inhibitor |
RPI-1 is a competitive, potent ATP-dependent Ret kinase inhibitor.
|
A11180 |
TG101209 |
JAK2 inhibitor |
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells. |
5 Item(s)
per page